Roche Global Development

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer	Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Fibrosis, Flaviviridae infectious disease, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, adenocarcinoma, carcinoma, chronic hepatitis B virus infection, chronic hepatitis C virus infection, cirrhosis of liver, epithelial neoplasm, hepatitis, hepatitis B virus infection, hepatitis C virus infection, hepatocellular carcinoma, infectious disease, liver disorder, neoplasm, viral hepatitis, viral infectious disease	Enrolling by invitation	Not applicable	2026-04-24		NCT07298577

Clinical trials